Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 1,262 | 837 | 513 | 2,076 | 2,841 |
| Operating Income | -1,262 | -837 | -513 | -2,076 | -2,841 |
| Interest Expense | 57 | 44 | 40 | 20 | 173 |
| Other Income | 668 | 1,660 | 0 | 0 | 0 |
| Pre-tax Income | -652 | 779 | -553 | -2,097 | -3,014 |
| Net Income Continuous | -652 | 779 | -553 | -2,097 | -3,014 |
| Minority Interests | -134 | -88 | -118 | -202 | -96 |
| Net Income | $-518 | $867 | $-435 | $-1,894 | $-2,918 |
| EPS Basic Total Ops | -0.02 | 0.05 | -0.03 | -0.13 | -0.28 |
| EPS Basic Continuous Ops | -0.03 | 0.05 | -0.04 | -0.15 | -0.23 |
| EPS Diluted Total Ops | -0.02 | 0.05 | -0.03 | -0.13 | -0.28 |
| EPS Diluted Continuous Ops | -0.03 | 0.05 | -0.04 | -0.15 | -0.23 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -0.28 |
| EBITDA(a) | $-1,255 | $-789 | $-460 | $-2,029 | $-2,821 |